Navigation Links
AstraZeneca and Sarah Cannon Research Institute Join Efforts to Fight Cancer
Date:1/11/2011

cing the field of cancer research. The collaboration is unique because SCRI will assist AstraZeneca with both the design and delivery of a new agent from its first studies in cancer patients to proof of concept at the conclusion of Phase II and we are delighted to be working with SCRI in this innovative way."

"We are pleased to engage in this strategic collaboration, bringing together some of the world's strongest physicians and scientists to optimize the development of new therapies for patients with cancer," said Dee Anna Smith, CEO of SCRI.  "We look forward to providing AstraZeneca with exceptional drug development services while leveraging an industry-leading opportunity to explore a new way for pharmaceutical drug development companies to collaborate."

"This type of strategic partnership is an exciting opportunity to demonstrate how clinical scientists and industry can collaborate for the greater good of patients. I believe the structure of the relationship will enable us to both adapt and move quickly from one study to the next as the clinical program progresses," said Howard A. "Skip" Burris III, M.D., SCRI chief medical officer and director of drug development. 

About AstraZeneca

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialisation of prescription medicines. As a leader in gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease medicines, AstraZeneca generated global revenues of US $32.8 billion in 2009.  For more information please visit: www.astrazeneca.com

SCRI Company

SCRI is a strategic research organization focusing on advancing therapies and accelerating drug development. It is one of the largest clinical research programs in the nation, conducting community-based clinical trials in oncology, car
'/>"/>

SOURCE AstraZeneca
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Combined Sales of Seven Emerging Therapies for Breast Cancer, Including Drugs From Sanofi-Aventis and AstraZeneca, Will Total Nearly $5 Billion by 2019
2. Rigel Earns Milestone Payments From AstraZeneca
3. TB Alliance and AstraZeneca Form Research Collaboration to Fight Tuberculosis
4. AstraZeneca Outlines Principles for Product-Related Online Communications
5. AstraZeneca CEO Interviewed on Q4 and Full-Year Results 2009
6. AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease
7. AstraZeneca and Nektar Sign Worldwide Agreement for Nektar Drug Development Programmes -- NKTR-118 and NKTR-119 -- to Address Opioid-Induced Constipation
8. AstraZeneca Calls on All Americans to Join US AGAINST ATHERO to Fight the Nations Number One Killer
9. BioDuro and AstraZeneca Expand Collaboration to Optimize Discovery Research for Respiratory and Inflammation Indications
10. Novartis/Schering-Ploughs Drug Will Replace AstraZenecas Symbicort as Decision Resources Clinical Gold Standard by 2012 for the Treatment of Asthma
11. AstraZeneca Implements Customized Cytel East(R) Software for More Accurate Trial Monitoring and Clinical Data Analysis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015   GenoSpace ... for the interpretation and analysis of genomic and ... Fischer has joined the company as Vice ... - http://photos.prnewswire.com/prnh/20150730/250931 "GenoSpace ... to integrate, interpret, analyze and explore complex sets ...
(Date:7/30/2015)... ... July 30, 2015 , ... The 2015 Market Research Report on the ... state of the global Propanol market with a focus on the Chinese situation. Major ... Mitsui Chemicals, Oxea, ISU Chemical, Sanofi, Royal Dutch Shell, LG Chem and Zhejiang Xinhua ...
(Date:7/30/2015)... CA (PRWEB) , ... July 30, 2015 , ... ... successful completion of a field clinical study of its canine osteoarthritis stem cell ... with Aratana Therapeutics (Kansas City, KS) and will be marketed in the US ...
(Date:7/30/2015)... July 30, 2015   Senomyx , Inc. (NASDAQ: ... science technologies to discover, develop, and commercialize novel flavor ... today reported financial results for the second quarter 2015. ... 2015, we remain on track to achieve our commercial ... Executive Officer of the Company. "Since our last quarterly ...
Breaking Biology Technology:GenoSpace Introduces Matthew Fischer as Vice President of Sales and Marketing 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 3VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9
... NVAX ) a clinical-stage vaccine company, announced today ... be presenting at,the Piper Jaffray 20th Annual Healthcare Conference ... York. Dr. Singhvi will provide an overview of the,company,s ... live,presentation can be accessed via the Company website at ...
... FHC ), which manufactures and markets the FC Female ... year ended,September 30, 2008. , ... revenues increased 52%,to $7.8 million, compared with $5.2 million in ... attributable to common stockholders of,$2.3 million, or $0.08 per diluted ...
... Regado Biosciences, Inc.,announced today David J. Mazzo, Ph.D., President ... Piper Jaffray Health Care Conference in New,York, NY, on ... Mazzo will discuss the Company,s development pipeline, in addition ... About Regado Biosciences , ...
Cached Biology Technology:The Female Health Company Reports Record Results for Fiscal Year 2008, at High End of Guidance 2The Female Health Company Reports Record Results for Fiscal Year 2008, at High End of Guidance 3The Female Health Company Reports Record Results for Fiscal Year 2008, at High End of Guidance 4The Female Health Company Reports Record Results for Fiscal Year 2008, at High End of Guidance 5The Female Health Company Reports Record Results for Fiscal Year 2008, at High End of Guidance 6The Female Health Company Reports Record Results for Fiscal Year 2008, at High End of Guidance 7The Female Health Company Reports Record Results for Fiscal Year 2008, at High End of Guidance 8
(Date:7/7/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company") ... announces a revised version of one of its first 30 second ... CNBC in New York , Chicago ... San Francisco metro areas.    , , ... replace all the cards in your wallet and keep your identity ...
(Date:7/2/2015)... Sweden , July 2, 2015 ... sensors FPC1025, FPC1035, FPC1145 and FPC1155 from the distributor World ... one of FPC,s distributors in Asia . ... 2015. The sensors will be used by smartphone manufacturers in ... MSEK is included in the communicated revenue guidance of approximately ...
(Date:6/29/2015)... 24, 2015 Research and ... "Latin America Biomedical Sensors Market - Growth, Trends ... The Latin America Biomedical Sensors market is estimated ... 2.04% over the period 2014-2020 The near ... the genetic formulation of each individual. These sensors can ...
Breaking Biology News(10 mins):Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2Latin America Biomedical Sensors Market Report 2015-2020 2
... SARS. Ebola. Bird Flu. Swine Flu. Rabies. These are ... one animal species into another and now infect humans. ... and scientists are working to determine what drives it. ... Tennessee, Knoxville, and department head in Ecology and Evolutionary ...
... (August 5, 2010) With global warming and climate ... reassuring to know that some creatures might cope by ... become less hospitable. Nevertheless, natural relocation of species is ... to Jessica Hellmann, Associate Professor at the University of ...
... , RIVERSIDE, Calif. Tobacco-related disease kills more people ... this problem, the University of California, Riverside has received ... Research Program ( TRDRP ), the most TRDRP grants ... more than $850,000, the grants will fund research on ...
Cached Biology News:UT professor uncovers clues into how viruses jump from hosts 2Butterflies shed light on how some species respond to global warming 2Butterflies shed light on how some species respond to global warming 3UC Riverside receives 6 grants for tobacco-related research 2UC Riverside receives 6 grants for tobacco-related research 3
... Lipid adsorption and clarification reagent; ... the purification of antibodies, proteins, nucleic ... has negligible cross-reactivity, and improves downstream ... a solid-phase, non-ionic adsorbent supplied as ...
A simple, sensitive and reliable method for determining free sulfhydryl content in peptides, protein...
... incubator-shaker, has the smallest footprint of all our ... x 680 mm (W x D) does not ... x 510mm). Available in 25 mm or 50 ... shaking applications requiring controlled speed and temperature ...
Request Info...
Biology Products: